Rabbit Anti-Shh Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Cohesin (Scc1 / Rad21) Monoclonal Antibody, Unconjugated, Clone CM110-2C10 from MBL International
Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Biology Products:(Date:11/20/2009)... METTLER TOLEDO recently announced tha...s Optimization Using At-Line Particle Characteriza.... In this webinar, the application of in situ par...design space and optimize a series of roller compa..., and roller compaction forces. , ...
(Date:11/19/2009)...le would like to be able to charge their cell phon...too often. A recent discovery made by UC San Diego...ercapacitors that could do just this. , In rece... , Prabhakar Bandaru, a professor in the UCSD Depa...ong with graduate student Mark Hoefer, have found ...
(Date:11/19/2009)...ATTLE, Nov. 19 Omeros Co...ed financial results for the third quarter ended S...ember 30, 2009, Omeros reported a net loss of $3.9... loss of $7.4 million, or $2.54 per share, for the...ptember 30, 2009, the Company reported a net loss ...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-First... innovator in biotechnology for diabetes therapy, ...ing services to food, supplement, biotechnology an...sed the previously reported $6.3 million registere...,760,870 shares of its common stock and warrants t...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3